Drug intelligence / Profile preview

Activomin

Development stage
Unknown
Lead developer
WH Pharmawerk Weinböhla
Modality
Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Activomin is a natural humic acid preparation, specifically containing the standardized WH67 humic acid extract derived from lignite (brown coal). Developed and manufactured by WH Pharmawerk Weinböhla GmbH, it is classified as a medical device in Germany rather than a conventional pharmaceutical drug. Activomin is primarily indicated for the treatment of gastrointestinal and metabolic disorders, including diarrhea-predominant irritable bowel syndrome (IBS-D), diarrheal diseases, and weakened immune defenses. Its mechanism of action involves the high-molecular-weight humic acids remaining largely unabsorbed in the gastrointestinal tract, where they act as an adsorbent to bind toxins, inflammatory mediators, and pathogens. Additionally, it is thought to modulate the colonic microbiome and support gut barrier function. The product is administered orally in capsule form and has been evaluated in randomized, double-blind, placebo-controlled clinical trials for symptom improvement in patients with IBS.

Brand names
Activomin
Other names
WH67 humic acidWH-67 humic acidWH 67 humic acidnatural humic acid

Beyond the preview

Go deeper on Activomin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Activomin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call